Sieuwerts, Anieta M <br/><br/>
How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Oct 2005 
 - 7311-21 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-05-0560  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADAM Proteins--genetics<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunohistochemistry<br/>Matrix Metalloproteinase 2--genetics<br/>Matrix Metalloproteinase 9--genetics<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Recurrence, Local<br/>Predictive Value of Tests<br/>Prognosis<br/>RNA, Messenger--genetics<br/>Receptors, Estrogen--genetics<br/>Receptors, Progesterone--genetics<br/>Retrospective Studies<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Survival Analysis<br/>Tamoxifen--therapeutic use